The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Abstract
Background : In 2015, the International Parkinson and Movement Disorder Society published clinical diagnostic criteria for Parkinson's disease. These criteria aimed to codify/reproduce the expert clinical diagnostic process and to help standardize diagnosis in research and clinical settings. Their accuracy compared with expert clinical diagnosis has not been tested. The objectives of this study were to validate the International Parkinson and Movement Disorder Society diagnostic criteria against a gold standard of expert clinical diagnosis, and to compare concordance/accuracy of the International Parkinson and Movement Disorder Society criteria to 1988 United Kingdom Brain Bank criteria. Methods : From 8 centers, we recruited 626 parkinsonism patients (434 PD, 192 non‐PD). An expert neurologist diagnosed each patient as having PD or non‐PD, regardless of International Parkinson and Movement Disorder Society criteria (gold standard, clinical diagnosis). Then a second neurologist evaluated the presence/absence of each individual item from the International Parkinson and Movement Disorder Society criteria. The overall accuracy/concordance rate, sensitivity, and specificity of the International Parkinson and Movement Disorder Society criteria compared with the expert gold standard were calculated. Results : Of 434 patients diagnosed with PD, 94.5% met the International Parkinson and Movement Disorder Society criteria for probable PD (5.5% false‐negative rate). Of 192 non‐PD patients, 88.5% were identified as non‐PD by the criteria (11.5% false‐positive rate). The overall accuracy for probable PD was 92.6%. In addition, 59.3% of PD patients and only 1.6% of non‐PD patients met the International Parkinson and Movement Disorder Society criteria for clinically established PD. In comparison, United Kingdom Brain Bank criteria had lower sensitivity (89.2%, P = 0.008), specificity (79.2%, P = 0.018), and overall accuracy (86.4%, P < 0.001). Diagnostic accuracy did not differ according to age or sex. Specificity improved as disease duration increased. Conclusions : The International Parkinson and Movement Disorder Society criteria demonstrated high sensitivity and specificity compared with the gold standard, expert diagnosis, with sensitivity and specificity both higher than United Kingdom Brain Bank criteria. © 2018 International Parkinson and Movement Disorder Society
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The diagnosis of PD was performed by at least two or more experienced neurologists based on the clinical diagnostic criteria proposed by International Parkinson and Movement Disorder Society (Postuma et al., 2018).”
From Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease (2022) · cites this paper as Postuma et al., 2018
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Self-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
Head injury and risk of Parkinson disease: A systematic review and meta‐analysis
Jafari, S., Etminan, M., Aminzadeh, F., & Samii, A. (2013) · Movement Disorders · doi:10.1002/mds.25458 · Cited by 282
Research works printed but not linked: 13
- 10.1002/mds.26431 · DOI
- 10.1002/mds.25844 · DOI
- 10.1002/mds.26796 · DOI
- 10.1016/0031-9384(84)90269-5 · DOI · Paper page
- 10.1097/00005537-199603000-00021 · DOI
- 10.1093/chemse/22.1.39 · DOI · Paper page
- Fleiss JL, 1981, Statistical Methods for Rates and Proportions
- 10.1016/j.bbr.2012.02.047 · DOI
- 10.1038/nrneurol.2016.152 · DOI
- 10.1093/brain/awx118 · DOI
- 10.1016/j.parkreldis.2014.05.011 · DOI
- 10.1136/jnnp.55.3.181 · DOI · Paper page
- 10.1212/WNL.57.8.1497 · DOI
Cited by
Sorted by citations
The epidemiology of Parkinson's disease
Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., & Tanner, C. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01419-8 · Cited by 967
Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.03.019 · Cited by 114
Gong, X., Huang, M., & Chen, L. (2022) · eneuro · doi:10.1523/eneuro.0393-21.2021 · Cited by 55
Siwik, C. J., Phillips, K., Litvan, I., Salmon, P., Rodgers, A., Jablonski, M., & Sephton, S. E. (2022) · Mindfulness · doi:10.1007/s12671-022-01874-y · Cited by 4
“Although PD is most commonly recognized by motor symptoms, defined as bradykinesia plus resting tremor or rigidity (Postuma et al., 2018), there are a number of non-motor changes that accompany PD, including disease-related distress, depression, anxiety, sleep disruption, including rapid eye…”
Self-citationParkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Metadata
- Authors
- Postuma, R. B., Poewe, W., Litvan, I., Lewis, S., Lang, A. E., Halliday, G., Goetz, C. G., Chan, P., Slow, E., Seppi, K., Schaffer, E., Rios‐Romenets, S., Mi, T., Maetzler, C., Li, Y., Heim, B., Bledsoe, I. O., & Berg, D.
- Affiliations
- Department of Neurology Montreal General Hospital Montreal Quebec Canada
- Department of Neurology Innsbruck Medical University Innsbruck Austria
- Department of Neurosciences UC San Diego La Jolla California USA
- Brain and Mind Centre, Sydney Medical School Camperdown Australia
- Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital Toronto Ontario Canada
- Rush University Medical Center Chicago Illinois USA
- Department of Neurobiology and Neurology Xuanwu Hospital of Capital Medical University Beijing People's Republic of China
- Klinik für Neurologie, UKSH, Campus Kiel, Christian‐Albrechts‐Universität Kiel Germany
- University of California San Francisco CA USA
- ORCID
- Halliday, Glenda
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2018-08-25
- Volume
- 33
- Issue
- 10
- Pages
- 1601-1608
- ISSN
- 0885-3185
- 1531-8257
- Cited by
- 283
- References
- 4
- Language
- en
- Funders
- Michael J. Fox Foundation for Parkinson's Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Validation of the MDS clinical diagnostic criteria for Parkinson's disease. https://app.cochat.ai/papers/10.1002/mds.27362
- The paper
- Postuma, R. B., Poewe, W., Litvan, I., Lewis, S., Lang, A. E., Halliday, G., Goetz, C. G., Chan, P., Slow, E., Seppi, K., Schaffer, E., Rios‐Romenets, S., Mi, T., Maetzler, C., Li, Y., Heim, B., Bledsoe, I. O., & Berg, D. (2018). Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.27362